Kenneth A Bauer Selected Research

Orthopedic Procedures

8/2004	Superiority of fondaparinux over enoxaparin in preventing venous thromboembolism in major orthopedic surgery using different efficacy end points.
3/2004	Fondaparinux: a new synthetic and selective inhibitor of Factor Xa.
12/2003	New pentasaccharides for the prophylaxis of venous thromboembolism: clinical studies.
9/2003	Fondaparinux, the first selective factor Xa inhibitor.
11/2002	Fondaparinux: basic properties and efficacy and safety in venous thromboembolism prophylaxis.
9/2002	Fondaparinux vs enoxaparin for the prevention of venous thromboembolism in major orthopedic surgery: a meta-analysis of 4 randomized double-blind studies.
9/2002	Factor Xa inhibition in the prevention of venous thromboembolism and treatment of patients with venous thromboembolism.
1/2002	Fondaparinux, a synthetic pentasaccharide: the first in a new class of antithrombotic agents - the selective factor Xa inhibitors.
1/2002	A new antithrombotic strategy, the selective inhibition of coagulation factors, and its importance to the orthopedic specialist.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kenneth A Bauer Research Topics

Disease

35	Venous Thromboembolism 01/2022 - 01/2002
24	Hemorrhage 01/2022 - 01/2002
14	Venous Thrombosis (Deep-Vein Thrombosis) 12/2020 - 01/2002
13	Thrombosis (Thrombus) 12/2020 - 01/2002
8	Neoplasms (Cancer) 01/2020 - 11/2009
6	Pulmonary Embolism 11/2020 - 08/2004
5	Thrombocytopenia (Thrombopenia) 07/2020 - 12/2003
5	Thrombophilia 01/2020 - 10/2005
5	Atrial Fibrillation 01/2019 - 01/2006
4	Stroke (Strokes) 10/2013 - 01/2006
3	Wounds and Injuries (Trauma) 11/2018 - 01/2010
3	Acute Coronary Syndrome 01/2006 - 09/2003
3	Thromboembolism 10/2004 - 05/2002
2	Intracranial Hemorrhages (Intracranial Hemorrhage) 12/2020 - 10/2017
2	Critical Illness (Critically Ill) 01/2020 - 11/2018
2	hereditary Thrombophilia 01/2007 - 12/2004
2	Myocardial Infarction 08/2006 - 10/2003
1	Clinical Deterioration 12/2020
1	Postthrombotic Syndrome 12/2020
1	COVID-19 07/2020
1	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 01/2020
1	Abdominal Aortic Aneurysm 01/2019
1	Flank Pain 01/2019
1	Vascular System Injuries 01/2019
1	Traumatic Intracranial Hemorrhage 10/2017
1	Craniocerebral Trauma (Head Injury) 10/2017
1	Antithrombin III Deficiency 01/2016
1	Hemophilia A (Haemophilia) 03/2015
1	Hereditary Angioedemas 11/2014
1	Body Weight (Weight, Body) 01/2013
1	Ischemic Stroke 07/2010
1	Pancreatic Neoplasms (Pancreatic Cancer) 11/2009
1	Osteoporosis 06/2008
1	Hematoma 01/2008

Drug/Important Bio-Agent (IBA)

17	Fondaparinux (Arixtra)FDA Link 09/2008 - 01/2002
16	Enoxaparin (Lovenox)FDA LinkGeneric 01/2020 - 01/2002
12	AnticoagulantsIBA 01/2020 - 10/2005
9	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 01/2020 - 01/2002
8	AntithrombinsIBA 01/2020 - 03/2003
7	Heparin (Liquaemin)FDA LinkGeneric 07/2020 - 06/2002
6	Factor Xa InhibitorsIBA 01/2022 - 01/2002
6	RivaroxabanIBA 01/2019 - 06/2007
5	Prothrombin (Factor II)IBA 01/2022 - 01/2002
5	Factor Xa (Coagulation Factor Xa)IBA 01/2022 - 05/2002
5	Vitamin K FDA Link 04/2011 - 10/2004
4	fibrin fragment D (D-dimer)IBA 01/2019 - 01/2015
4	Warfarin (Coumadin)FDA LinkGeneric 01/2013 - 04/2003
4	factor V LeidenIBA 01/2007 - 01/2002
3	Thromboplastin (Tissue Factor)IBA 02/2013 - 10/2002
3	Thrombin FDA Link 01/2013 - 10/2002
2	PRT064445IBA 01/2022 - 01/2019
2	Pharmaceutical PreparationsIBA 01/2019 - 09/2008
2	Antiphospholipid AntibodiesIBA 10/2018 - 10/2005
2	Dabigatran FDA Link 06/2013 - 01/2013
2	Factor VII (Proconvertin)IBA 07/2010 - 10/2005
2	argatroban (MPQA)FDA Link 02/2006 - 01/2006
2	ximelagatran (Exanta)IBA 02/2006 - 01/2006
2	ProdrugsIBA 02/2006 - 01/2006
2	lepirudin (Refludan)FDA Link 02/2006 - 01/2006
2	melagatranIBA 02/2006 - 01/2006
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2022
1	Fibrinolytic Agents (Antithrombotic Agents)IBA 12/2020
1	AntibodiesIBA 07/2020
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2020
1	Factor XI (Plasma Thromboplastin Antecedent)IBA 01/2020
1	FibrinIBA 01/2019
1	isoquercitrinIBA 01/2019
1	FlavonoidsIBA 01/2019
1	IsomerasesIBA 01/2019
1	QuercetinIBA 01/2019
1	Sulfhydryl Compounds (Thiols)IBA 01/2019
1	Protein Disulfide-IsomerasesIBA 01/2019
1	Estrogens (Estrogen)FDA Link 01/2016
1	Blood Coagulation Factors (Coagulation Factor)IBA 03/2015
1	Complement C1 Inhibitor Protein (C1 Esterase Inhibitor)IBA 11/2014
1	Biological ProductsIBA 10/2013
1	apixabanIBA 01/2013
1	Diclofenac (SR 38)FDA LinkGeneric 11/2010
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 11/2010
1	KetorolacIBA 11/2010
1	Investigational DrugsIBA 03/2010
1	Tyr sulfate(1)- enkephalinamide-Leu (LETS)IBA 05/2009
1	Factor IX (Coagulation Factor IX)FDA LinkGeneric 05/2009
1	AntigensIBA 05/2009
1	betrixabanIBA 01/2009
1	Blood Proteins (Serum Proteins)IBA 06/2008

Therapy/Procedure

16	Therapeutics 12/2020 - 01/2002
9	Orthopedic Procedures 08/2004 - 01/2002
2	Knee Replacement Arthroplasty (Total Knee Replacement) 01/2013 - 05/2009
1	Replacement Arthroplasty 01/2022
1	Catheters 12/2020
1	Thrombolytic Therapy 12/2020
1	Thrombectomy 12/2020
1	Chemoprevention 01/2020
1	Critical Care (Surgical Intensive Care) 01/2020
1	Long-Term Care 11/2018
1	Lymph Node Excision (Lymph Node Dissection) 11/2014
1	Injections 01/2013
1	Secondary Prevention 01/2013
1	Length of Stay 05/2009